Zatloukal Innovations
  • Home
  • Team
  • Projects & Services
    • Diagnostics development and regulatory advice
    • Cybersecurity for health data
    • Medicines for Future
  • News
  • Partners
  • Contact
Select Page

An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters

by Zatloukal Innovations | May 22, 2025 | Plant Molecular Pharming

Föderl-Höbenreich E, Izadi S, Hofacker L, Kienzl NF, Castilho A, Strasser R, Tarrés-Freixas F, Cantero G, Roca N, Pérez M, Lorca-Oró C, Usai C, Segalés J, Vergara-Alert J, Mach L, Zatloukal K. An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral...

Recent Posts

  • An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters
  • Science Summit 77th General Assembly of the UN: “Green Medicines: Plant Molecular Farming and a New Collaboration Model for Addressing Global Health Challenges”
  • PRESS RELEASE: Austrian iniative Medicines for Future launches development of COVID-19 therapy with South Africa
  • AU-EU Summit: Green Medicines in Africa
  • “Markt und Mittelstand” reports on M4F initiative
© 2023 Zatloukal Innovations GmbH | Imprint